FC101 and analogs as a method of treatment for cancer
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 18, 2006
Grant Date -
May 13, 2004
app pub date -
Oct 29, 2003
filing date -
Nov 21, 1997
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides a treatment for angiogenic diseases, including solid tumors. The treatment consists of administering therapeutically active dosages of FC101, resulting in a reduction in endothelial cell proliferation and inhibition of new blood vessel formation. FC101 can also be used as a lead compound to develop other pharmacologically-active compounds, by adding or substituting different functional groups for those already present on the FC101 molecule.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully